CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell targeted therapies.
暂无分享，去创建一个
T. Maisonobe | A. Echaniz-Laguna | J. Antoine | V. Leblond | M. Michaud | J. Franques | F. Bouhour | C. Tard | A. Créange | B. Arnulf | A. Puma | E. Delmont | C. Rossi | E. Lagrange | L. Magy | K. Viala | G. Morel | L. Simon | M. Baron | D. Roos-Weil | Marie Le cann | Laurence Simon